Moderately hypofractionated versus conventionally fractionated radiation therapy with temozolomide for young and fit patients with glioblastoma: an institutional experience and meta-analysis of literature

被引:0
|
作者
Phoebe Chidley
Mihir Shanker
Claire Phillips
Neda Haghighi
Mark B. Pinkham
James R. Whittle
Joseph Sia
机构
[1] Christchurch Hospital,Department of Radiation Oncology
[2] Princess Alexandra Hospital,Department of Radiation Oncology
[3] University of Queensland,Department of Radiation Oncology
[4] Peter MacCallum Cancer Centre,Department of Medical Oncology
[5] Epworth Radiation Oncology and Icon Group,Personalised Oncology Division
[6] Peter MacCallum Cancer Centre,Department of Medical Biology
[7] The Walter and Eliza Hall Institute of Medical Research,Sir Peter MacCallum Department of Oncology
[8] University of Melbourne,undefined
[9] The University of Melbourne,undefined
来源
Journal of Neuro-Oncology | 2022年 / 160卷
关键词
Glioblastoma; Radiotherapy; Hypofractionation; Temozolomide; Overall survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:361 / 374
页数:13
相关论文
共 50 条
  • [1] Moderately hypofractionated versus conventionally fractionated radiation therapy with temozolomide for young and fit patients with glioblastoma: an institutional experience and meta-analysis of literature
    Chidley, Phoebe
    Shanker, Mihir
    Phillips, Claire
    Haghighi, Neda
    Pinkham, Mark B.
    Whittle, James R.
    Sia, Joseph
    JOURNAL OF NEURO-ONCOLOGY, 2022, 160 (02) : 361 - 374
  • [2] Hypofractionated versus standard radiation therapy in combination with temozolomide for glioblastoma in the elderly: a meta-analysis
    Lu, Victor M.
    Kerezoudis, Panogiotis
    Brown, Desmond A.
    Burns, Terry C.
    Quinones-Hinojosa, Alfredo
    Chaichana, Kaisorn L.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 143 (02) : 177 - 185
  • [3] Hypofractionated versus standard radiation therapy in combination with temozolomide for glioblastoma in the elderly: a meta-analysis
    Victor M. Lu
    Panogiotis Kerezoudis
    Desmond A. Brown
    Terry C. Burns
    Alfredo Quinones-Hinojosa
    Kaisorn L. Chaichana
    Journal of Neuro-Oncology, 2019, 143 : 177 - 185
  • [4] Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature
    Francolini, G.
    Detti, B.
    Becherini, C.
    Caini, S.
    Ingrosso, G.
    Di Cataldo, Vanessa
    Stocchi, G.
    Salvestrini, V.
    Lancia, A.
    Scartoni, D.
    Giacomelli, I.
    Sardaro, A.
    Carbonara, R.
    Borghesi, S.
    Aristei, C.
    Livi, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
  • [5] Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma
    Wang, Tony J. C.
    Wu, Cheng-Chia
    Jani, Ashish
    Estrada, Juan
    Ung, Timothy
    Chow, Daniel S.
    Soun, Jennifer E.
    Saad, Shumaila
    Qureshi, Yasir H.
    Gartrell, Robyn
    Saadatmand, Heva J.
    Saraf, Anurag
    Garrett, Matthew D.
    Grubb, Christopher
    Isaacson, Steven R.
    Cheng, Simon K.
    Sisti, Michael B.
    Bruce, Jeffrey N.
    Sheth, Sameer A.
    Lassman, Andrew B.
    Iwamoto, Fabio M.
    McKhann, Guy M., II
    PRACTICAL RADIATION ONCOLOGY, 2016, 6 (05) : 306 - 314
  • [6] Hypofractionated Versus Standard Radiation Therapy With or Without Temozolomide for Older Glioblastoma Patients
    Arvold, Nils D.
    Tanguturi, Shyam K.
    Aizer, Ayal A.
    Wen, Patrick Y.
    Reardon, David A.
    Lee, Eudocia Q.
    Nayak, Lakshmi
    Christianson, Laura W.
    Horvath, Margaret C.
    Dunn, Ian F.
    Golby, Alexandra J.
    Johnson, Mark D.
    Claus, Elizabeth B.
    Chiocca, E. Antonio
    Ligon, Keith L.
    Alexander, Brian M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 384 - 389
  • [7] Hypofractionated Versus Standard Radiation Therapy With or Without Temozolomide for Older Glioblastoma Patients
    Fiorica, Francesco
    Colella, Maria
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (04): : 939 - 939
  • [8] Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials
    Lehrer, Eric J.
    Kishan, Amar U.
    Yu, James B.
    Trifiletti, Daniel M.
    Showalter, Timothy N.
    Ellis, Rodney
    Zaorsky, Nicholas G.
    RADIOTHERAPY AND ONCOLOGY, 2020, 148 : 235 - 242
  • [9] Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience
    Rayan, Amal
    Abdel-Kareem, Samya
    Hasan, Huda
    Zahran, Asmaa M.
    Gamal, Doaa A.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (06) : 890 - 898
  • [10] A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients
    An-an Yin
    Sang Cai
    Yu Dong
    Lu-hua Zhang
    Bo-lin Liu
    Jin-xiang Cheng
    Xiang Zhang
    Journal of Neuro-Oncology, 2014, 116 : 315 - 324